启迪药业：公司总裁冯雪、副总裁蔡军辞职

Group 1 - The company announced the resignation of Mr. Feng Xue as President and Mr. Cai Jun as Vice President due to work changes and career planning, respectively [1] - After their resignations, both individuals will no longer hold any positions within the company or its subsidiaries [1] - For the first half of 2025, the company's revenue composition shows that traditional Chinese medicine and health products account for 94.02%, while other products account for 5.98% [1] Group 2 - As of the report date, the company's market capitalization is 2.8 billion yuan [1]